ArticleCancers2022

TRAIL-Based Therapies Efficacy in Pediatric Bone Tumors Models Is Modulated by TRAIL Non-Apoptotic Pathway Activation via RIPK1 Recruitment.

Régis Brion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.